Nephros (NEPH) EBT Margin Growth (3y) (2013 - 2026)
Powered by 
Analysis
Nephros (NEPH) EBT Margin Growth (3y) (2013 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 178.01 Bn | 172.41 Bn | 7.27 Bn | -429.00 |
| 2 | Intuitive Surgical | 131.29 Bn | 126.08 Bn | 1.96 Bn | 803.00 |
| 3 | Medtronic | 116.38 Bn | 107.56 Bn | 6.34 Bn | 260.00 |
| 4 | Stryker | 106.01 Bn | 102.53 Bn | 4.50 Bn | 574.00 |
| 5 | Boston Scientific | 63.40 Bn | 62.86 Bn | 3.85 Bn | 764.00 |
| 6 | Edwards Lifesciences | 48.89 Bn | 44.64 Bn | 1.35 Bn | 835.00 |
| 7 | Alcon | 32.59 Bn | 31.13 Bn | 1.68 Bn | -1,045.00 |
| 8 | Dexcom | 31.84 Bn | 29.89 Bn | 830.00 Mn | 598.00 |
| 9 | Steris | 20.61 Bn | 20.13 Bn | 684.20 Mn | 423.00 |
| 10 | Nephros | 48.31 Mn | 43.62 Mn | 4.03 Mn | 3,201.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3,201.00 |
| Mar 31, 2026 | 990.00 |
| Dec 31, 2025 | 2,825.00 |
| Sep 30, 2025 | 6,031.00 |
| Jun 30, 2025 | 3,430.00 |
| Mar 31, 2025 | 8,305.00 |
| Dec 31, 2024 | 3,617.00 |
| Sep 30, 2024 | 3,662.00 |
| Jun 30, 2024 | 4,076.00 |
| Mar 31, 2024 | 3,167.00 |
| Dec 31, 2023 | 569.00 |
| Sep 30, 2023 | 3,971.00 |
| Jun 30, 2023 | 9,108.00 |
| Mar 31, 2023 | 3,425.00 |
| Dec 31, 2022 | -1,599.00 |
| Sep 30, 2022 | -2,917.00 |
| Jun 30, 2022 | 1,085.00 |
| Mar 31, 2022 | 417.00 |
| Dec 31, 2021 | 2,001.00 |
| Sep 30, 2021 | 2.00 |